Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Christiansen

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Diabetes Technology & Therapeutics|August 1, 2018
Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 DiabetesRobert H Slover, Jeanie B Tryggestad, Linda A DiMeglio, et al.
Nature Medicine|October 3, 2022
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.
Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Diabetes Technology & Therapeutics|December 6, 2022
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled TrialSatish K Garg, George Grunberger, Ruth Weinstock, et al.
Frontiers in Endocrinology|January 5, 2026
Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trialJohan H Jendle, Satish K Garg, Charles Thivolet, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Diabetes Technology & Therapeutics|August 1, 2018
Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 DiabetesRobert H Slover, Jeanie B Tryggestad, Linda A DiMeglio, et al.
Nature Medicine|October 3, 2022
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.
Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Diabetes Technology & Therapeutics|December 6, 2022
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled TrialSatish K Garg, George Grunberger, Ruth Weinstock, et al.
Frontiers in Endocrinology|January 5, 2026
Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trialJohan H Jendle, Satish K Garg, Charles Thivolet, et al.
Pageof 3